LEADIANT BIOSCIENCES LIMITED - Profile & Financials

CompanyTrack

Previous Company Names

SIGMA-TAU RARE DISEASE LIMITED 15 Apr 2015 — 5 Dec 2016

Accounts Submitted 4 Oct 2025 Next due 30 Sept 2026 2 months remaining

Confirmation Submitted 22 Apr 2026 Next due 29 Apr 2027 9 months remaining

Net assets £40M £18M 2024 year on year

Total assets £66M £19M 2024 year on year

Total Liabilities £26M £951K 2024 year on year

Charges None No charges registered

Contact & Details

Contact

Registered Address

21 Holborn Viaduct London EC1A 2DY United Kingdom

Telephone

0800 000 0000

info@example.com

Website

www.example.com

Full company profile for LEADIANT BIOSCIENCES LIMITED (09544704), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 15 Apr 2015. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Period 1 Jan → 31 Dec 2024

Type full

Next accounts 31 Dec 2025

Due by 30 Sept 2026 2 months remaining

Balance Sheet & P&L (2015–2024)

Cash in Bank

£1.77M

Increased by £1.13M (+176%)

Net Assets

£39.79M

Increased by £18.29M (+85%)

Total Liabilities

£26.44M

Increased by £950.63k (+4%)

Turnover

£35.40M

Increased by £65.14k (+0%)

Employees

Decreased by 1 (-11%)

Debt Ratio

40%

Decreased by 14 (-26%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 31 Dec Year End	2023 31 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

2 active 1 resigned

Show resigned officers

						Status
Laureti, Lorenza	Director	Italian	Italy	60	1 Apr 2022	Active
Sisec Limited	Corporate-secretary	United Kingdom	Unknown	—	15 Apr 2015	Active

Shareholders

Shareholders (1)


Essetifin S.p.a.	100.0%

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

No group structure identified

Charges

No charges registered

Properties

0 total

No related properties

Documents

Company Filings

Date	Category	Description
22 Apr 2026	Confirmation Statement	Confirmation statement made on 15 Apr 2026 with no updates
4 Feb 2026	Officers	Appointment of Mr Dan-Paul Andreianu as director on 1 Feb 2026
19 Jan 2026	Officers	Termination of Antonio Manuel Maia Devesa Gama Da Silva as director on 18 Jan 2026
4 Oct 2025	Accounts	Annual accounts made up to 31 Dec 2024
30 Jul 2025	Officers	Appointment of Daniella Toncheva as director on 25 Jul 2025

22 Apr 2026 Confirmation Statement

Confirmation statement made on 15 Apr 2026 with no updates

4 Feb 2026 Officers

Appointment of Mr Dan-Paul Andreianu as director on 1 Feb 2026

19 Jan 2026 Officers

Termination of Antonio Manuel Maia Devesa Gama Da Silva as director on 18 Jan 2026

4 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

30 Jul 2025 Officers

Appointment of Daniella Toncheva as director on 25 Jul 2025

Recent Activity

Latest Activity

Confirmation statement made on 15 Apr 2026 with no updates

2 months ago on 22 Apr 2026

Appointment of Mr Dan-Paul Andreianu as director on 1 Feb 2026

4 months ago on 4 Feb 2026

Termination of Antonio Manuel Maia Devesa Gama Da Silva as director on 18 Jan 2026

5 months ago on 19 Jan 2026

Annual accounts made up to 31 Dec 2024

9 months ago on 4 Oct 2025

Appointment of Daniella Toncheva as director on 25 Jul 2025

11 months ago on 30 Jul 2025